![Paul Hastings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Hastings
Vorstandsvorsitzender bei
NKARTA, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Paul J.
Hastings is the founder of Termeer Foundation, established in 2023, serving as Director.
Current jobs include Chief Executive Officer & Director at Nkarta, Inc. since 2024, Chairman at Specific Biologics, Inc. starting 2025, Director at Pacira Pharmaceuticals, Inc. (California), Director at California Biomedical Innovation Alliance, Director at California Life Sciences Association since 2013, and Independent Director at enGene Therapeutics, Inc. since 2024.
Former jobs include President & Chief Executive Officer at LXR Biotechnology, Inc. (1998–1999), President & Chief Executive Officer at Axys Pharmaceuticals, Inc. (2000–2002), President & Chief Executive Officer at QLT, Inc. (2002–2006), Chairman, President & Chief Executive Officer at Mereo BioPharma 5, Inc. (2013–2018), Chairman at Proteon Therapeutics, Inc., Vice Chairman at Biotechnology Innovation Organization, Chairman at Proteolix, Inc. (2008–2009), Chairman at Pacira Biosciences, Inc. (2024–2025), Director at ViaCell, Inc. (2000–2007), Director at Arriva Pharmaceuticals, Inc., Director at ViaCyte, Inc., Director at Cerimon Pharmaceuticals, Inc., Director at California Healthcare Institute, Director at The Bay Area Bioscience Association, Independent Director at Relypsa, Inc. (2013–2016), GM-European Division, VP-Sales & Marketing at Synergen, Inc., President-Worldwide Therapeutics at Genzyme Corp.
(1994–1998), Principal at Hoffmann-La Roche, Inc., and President at CHIRON Biopharmaceuticals (1999–2001).
Education includes undergraduate degree from the University of Rhode Island, conferred in 1984.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NKARTA, INC. 0.55% | 18.06.2026 | 390’247 ( 0.55% ) | 1 Mio $ | 31.05.2026 |
| 16.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Paul Hastings
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Vorstandsvorsitzender | 01.02.2018 |
| ENGENE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 15.05.2024 |
Termeer Foundation
 Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of patient-centered healthcare solutions. The private company is based in Boston. It offers leadership programs, including the Termeer Fellows Program, which supports first-time CEOs of early-stage or nonprofit biotech organizations through mentorship, executive coaching, and networking. The foundation fosters a diverse and inclusive community of entrepreneurs, academics, and students, and maintains a network of mentors, advisors, and alumni to strengthen collaboration and innovation. The American company was founded by Alan E. Walts. | Gründer | 01.06.2023 |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Direktor/Vorstandsmitglied | - |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direktor/Vorstandsmitglied | 01.01.2013 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Direktor/Vorstandsmitglied | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Vorsitzender | 11.06.2025 |
Ehemalige bekannte Positionen von Paul Hastings
| Unternehmen | Position | Ende |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Vorsitzender | 28.01.2025 |
| ONCOMED PHARMACEUTICALS INC | Vorstandsvorsitzender | 01.01.2018 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Paul Hastings
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
LXR Biotechnology, Inc.
 LXR Biotechnology, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics to treat diseases | Health Technology |
Synergen, Inc.
 Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Health Technology |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
CHIRON Biopharmaceuticals | |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Commercial Services |
Termeer Foundation
Termeer Foundation Movies/EntertainmentConsumer Services The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of patient-centered healthcare solutions. The private company is based in Boston. It offers leadership programs, including the Termeer Fellows Program, which supports first-time CEOs of early-stage or nonprofit biotech organizations through mentorship, executive coaching, and networking. The foundation fosters a diverse and inclusive community of entrepreneurs, academics, and students, and maintains a network of mentors, advisors, and alumni to strengthen collaboration and innovation. The American company was founded by Alan E. Walts. | Consumer Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
